pharmadog
News
when
  • Latest
  • Archive
by source
  • All Sources
  • Sources Page
Jobs
department
  • Clinical
  • Regulatory
  • Medical Affairs
  • Commercial
  • R&D / Discovery
  • Biostatistics / Data
  • Manufacturing / CMC
  • Market Access
therapeutic area
  • Oncology
  • Immunology
  • Neuroscience
  • Cardiovascular
  • Metabolic
  • Rare Disease
  • Infectious Disease
location & type
  • Remote Only
  • US Only
  • California
  • Massachusetts
  • Internships
  • Phase 3 Roles
  • All Jobs →
Drugs
by stage
  • Marketed
  • Phase 3
  • Phase 2
  • Phase 1
  • Preclinical
browse
  • Most catalysts
  • Recently active
  • All drugs →
  • Companies
  • Patent cliff
Calendar
what
  • Trial readouts
  • PDUFA dates
  • Approvals
  • Earnings
when
  • Upcoming
  • Month grid
  • Recently passed
Sign InSubscribe
pharmadog

fetch the data · sniff the signal

Discover
  • Jobs
  • News
  • Drugs
  • Calendar
  • Companies
Hubs
  • Topics
  • Patent cliff
  • Publications
  • Readouts
Tools
  • Compare
  • Search
  • Bookmarks
Trust
  • About
  • Sources
  • Contact
Legal
  • Privacy
  • Terms
  • Pricing

© 2026 pharmadog.xyz

made by humans and a good dog

  • home
  • jobs
  • news
  • search
the cabinet

Drugs

6,918 products tracked · 6,918 matching

★ save view↓export CSV
phase
allMarketedPhase 3Phase 2Phase 1Preclinical
sort
catalystsrecentname
therapeutic area
allOncology1831Infectious Disease718Cardiology425Pulmonology396Immunology371Ophthalmology368Dermatology300Women's Health
viewlistcards
Marketed
octreotide acetate DR
Mycapssa (octreotide acetate)
Acromegaly
Chiasma Inc
0 catalysts
Phase 2
odafosfamide
odafosfamide [INN]
T-Cell Acute Lymphocytic Leukemia (T-Cell Acute Lymphoblastic Leukaemia)
OBI Pharma Inc
0 catalysts
Phase 2
odatroltide
odatroltide [INN]
Acute Ischemic Stroke
Lumosa Therapeutics Co Ltd
0 catalysts
Phase 3
← prev
page 201 of 231
next →
131
Pain89
Neurology1
odronextamab
Extranodal Marginal Zone B-Cell Lymphoma (Mucosa-Associated Lymphoid Tissue o…
B-lymphocyte antigen CD20T cell surface glycoprotein CD3
$REGNREGENERON PHARMACEUTICALS, INC.
0 catalysts
Phase 2
olafertinib
olafertinib [INN]
Non-Small Cell Lung Cancer
Checkpoint Therapeutics Inc
0 catalysts
Marketed
olanzapine pamoate XR
Zyprexa Relprevv (olanzapine pamoate)
Schizophrenia
CHEPLAPHARM Arzneimittel GmbH
0 catalysts
Phase 2
olaptesed pegol
olaptesed pegol [INN]
Glioblastoma Multiforme (GBM)
TME Pharma AG
0 catalysts
Phase 2
olatorepatide
olatorepatide [INN]
Obesity
$REGNREGENERON PHARMACEUTICALS, INC.
0 catalysts
Marketed
olezarsen sodium
Tryngolza (olezarsen sodium)
Hypertriglyceridemia
$IONSIONIS PHARMACEUTICALS INC
0 catalysts
Marketed
olipudase alfa
Xenpozyme (olipudase alfa)
Niemann-Pick Disease Type B (Acid Sphingomyelinase Deficiency)
Genzyme Corp
0 catalysts
Phase 2
olisutrigine bromide
olisutrigine bromide [INN]
Pruritus
Formation Bio Inc
0 catalysts
Marketed
olmesartan medoxomil
Olmesartan Medoxomil (olmesartan medoxomil)
Hypertension
Umedica Laboratories Pvt Ltd
0 catalysts
Marketed
olodaterol hydrochloride
Striverdi Respimat (olodaterol hydrochloride)
Chronic Bronchitis
Boehringer Ingelheim Corp
0 catalysts
Phase 3
olomorasib
Non-Small Cell Lung Cancer
Eli Lilly and Co
0 catalysts
Phase 3
olpasiran
Atherosclerosis
LPA mRNA
$AMGNAMGEN INC
0 catalysts
Marketed
olsalazine sodium
Dipentum (olsalazine sodium)
Ulcerative Colitis
Mylan Pharmaceuticals Inc
0 catalysts
Marketed
olutasidenib
Rezlidhia (olutasidenib)
Refractory Acute Myeloid Leukemia
$RIGLRIGEL PHARMACEUTICALS INC
0 catalysts
Phase 3
olverembatinib
Acute Lymphocytic Leukemia (ALL, Acute Lymphoblastic Leukemia)
Bcr/Abl fusion protein
$AAPGASCENTAGE PHARMA GROUP INTERNATIONAL
0 catalysts
Phase 3
olvimulogene nanivacirepvec
Endometrial Cancer
$GNLXGENELUX Corp
0 catalysts
Marketed
omacetaxine mepesuccinate
Myelodysplastic Syndrome (Preleukemia)
$TEVATEVA PHARMACEUTICAL INDUSTRIES LTD
0 catalysts
Marketed
omadacycline tosylate
Nuzyra (omadacycline tosylate)
Mycobacterium Infections
Bacterial 70S ribosome
Paratek Pharmaceuticals Inc
0 catalysts
Marketed
omalizumab
Xolair (omalizumab)
Chronic Urticaria
Genentech Inc
0 catalysts
Marketed
omaveloxolone
Skyclarys (omaveloxolone)
Friedreich Ataxia
Reata Pharmaceuticals Inc
0 catalysts
Marketed
omega-3-acid ethyl esters
Omega-3-Acid Ethyl Esters Prasco (omega-3-acid ethyl esters)
Hypertriglyceridemia
Prasco LLC
0 catalysts
Marketed
omeprazole magnesium DR
Omeprazole Magnesium (omeprazole magnesium)
Systemic Mastocytosis
Perrigo Pharmaceuticals Company (Inactive)
0 catalysts
Marketed
omidenepag isopropyl
Omlonti (omidenepag isopropyl)
Ocular Hypertension
Ocuvex Therapeutics Inc
0 catalysts
Phase 3
omidubicel
Omisirge (omidubicel-onlv)
Acute Lymphocytic Leukemia (ALL, Acute Lymphoblastic Leukemia)
Gamida Cell Ltd
0 catalysts
Phase 2
omilancor
omilancor [INN]
Ulcerative Colitis
NImmune Biopharma Inc
0 catalysts
Phase 2
ompenaclid succinate
Metastatic Colorectal Cancer
Inspirna Inc
0 catalysts
Preclinical
onCARlytics
Triple-Negative Breast Cancer (TNBC)
Imugene Ltd
0 catalysts